Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nonalcoholic Fatty Liver Disease (NAFLD): Pathogenesis and Noninvasive Diagnosis
Vicneswarry Dorairaj, Siti Aishah Sulaiman, Nadiah Abu, et al.
Biomedicines (2021) Vol. 10, Iss. 1, pp. 15-15
Open Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Markers of insulin resistance associated with non-alcoholic fatty liver disease in non-diabetic population
Pei Zeng, Xiangsheng Cai, Xiaozhou Yu, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 24
From fatty liver to fibrosis: the impact of miRNAs on NAFLD and NASH
Reda Mansour, Sherif S Abdel Mageed, Ahmed I. Abulsoud, et al.
Functional & Integrative Genomics (2025) Vol. 25, Iss. 1
Closed Access | Times Cited: 1
The Effect of Vitamin E Supplementation on Serum Aminotransferases in Non-Alcoholic Fatty Liver Disease (NAFLD): A Systematic Review and Meta-Analysis
Stamatina Vogli, Androniki Naska, Γεώργιος Μαρίνος, et al.
Nutrients (2023) Vol. 15, Iss. 17, pp. 3733-3733
Open Access | Times Cited: 22
Assessing the causal relationships between human blood metabolites and the risk of NAFLD: A comprehensive mendelian randomization study
Ziwei Guo, Tingyu Zhang, Zhangjun Yun, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 18
Fenofibrate alleviates NAFLD by enhancing the PPARα/PGC-1α signaling pathway coupling mitochondrial function
Xuemei Wang, Jieying Wang, Ying Cao, et al.
BMC Pharmacology and Toxicology (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 6
Vitamin E improves serum markers and histology in adults with metabolic dysfunction‐associated steatotic liver disease: Systematic review and meta‐analysis
N. Chee, Ram Prasad Sinnanaidu, Wah‐Kheong Chan
Journal of Gastroenterology and Hepatology (2024)
Open Access | Times Cited: 6
Insights into the roles and pathomechanisms of ceramide and sphigosine-1-phosphate in nonalcoholic fatty liver disease
Cheng Zhu, Qian Huai, Xu Zhang, et al.
International Journal of Biological Sciences (2022) Vol. 19, Iss. 1, pp. 311-330
Open Access | Times Cited: 26
Curcumin Alleviates High-fat Diet-induced Nonalcoholic Steatohepatitis via Improving Hepatic Endothelial Function with Microbial Biotransformation in Rats
Jiazhen Wu, Mengyao Li, Ning Huang, et al.
Journal of Agricultural and Food Chemistry (2023) Vol. 71, Iss. 27, pp. 10338-10348
Closed Access | Times Cited: 16
Genetic Predictors of Comorbid Course of COVID-19 and MAFLD: A Comprehensive Analysis
Mykhailo Buchynskyi, Valentyn Oksenych, Iryna Kamyshna, et al.
Viruses (2023) Vol. 15, Iss. 8, pp. 1724-1724
Open Access | Times Cited: 13
Excess cardiovascular mortality in men with non-alcoholic fatty liver disease: A cause for concern!
Akash Batta, Juniali Hatwal
World Journal of Cardiology (2024) Vol. 16, Iss. 7, pp. 380-384
Open Access | Times Cited: 5
Genetic Polymorphisms and Diversity in Nonalcoholic Fatty Liver Disease (NAFLD): A Mini Review
Siti Aishah Sulaiman, Vicneswarry Dorairaj, Muhammad Nafiz Haidi Adrus
Biomedicines (2022) Vol. 11, Iss. 1, pp. 106-106
Open Access | Times Cited: 20
A Review of the Effects of Fucoxanthin on NAFLD
Nor Hafiza Sayuti, Khairul Najmi Muhammad Nawawi, Jo Aan Goon, et al.
Nutrients (2023) Vol. 15, Iss. 8, pp. 1954-1954
Open Access | Times Cited: 11
Targeting BMP-1 enhances anti-tumoral effects of doxorubicin in metastatic mammary cancer: common and distinct features of TGF-β inhibition
Nuray Erin, Esra Tavşan, Seren Haksever, et al.
Breast Cancer Research and Treatment (2025)
Open Access
COMPARATIVE ANALYSIS OF THE TOTAL PROTEOME IN NONALCOHOLIC STEATOHEPATITIS: IDENTIFICATION OF POTENTIAL BIOMARKERS
Eda Ates, Hien Thi My Ong, Seung-Min Yu, et al.
Molecular & Cellular Proteomics (2025), pp. 100921-100921
Open Access
Unveiling NLR pathway signatures: EP300 and CPN60 markers integrated with clinical data and machine learning for precision NASH diagnosis
Marwa Matboli, Noha E. El-Attar, Ibrahim Abdelbaky, et al.
Cytokine (2025) Vol. 188, pp. 156882-156882
Closed Access
The effect of chitosan supplementation on liver function, hepatic steatosis predictors, and metabolic indicators in adults with non-alcoholic fatty liver disease: a randomized, double-blinded, placebo-controlled, clinical trial
Mohammad Ali Mohsenpoor, Karim Parastouei, Maryam Taghdir, et al.
Journal of Health Population and Nutrition (2025) Vol. 44, Iss. 1
Open Access
The association between estimated glucose disposal rate and metabolic dysfunction-associated steatotic liver disease and liver fibrosis in US adults
Wanqian Liu, Xiaozhong Li, Chen Ling, et al.
BMC Endocrine Disorders (2025) Vol. 25, Iss. 1
Open Access
Aberrant Spontaneous Brain Activity and its Association with Cognitive Function in Non-Obese Nonalcoholic Fatty Liver Disease: A Resting-State fMRI Study
Jia-Li Xu, Jia-Ping Gu, Liyan Wang, et al.
Journal of Integrative Neuroscience (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 10
Preventative and Therapeutic Effects of Astaxanthin on NAFLD
Nor Hafiza Sayuti, Khairul Najmi Muhammad Nawawi, Jo Aan Goon, et al.
Antioxidants (2023) Vol. 12, Iss. 8, pp. 1552-1552
Open Access | Times Cited: 10
Novel proteomic signatures may indicate MRI-assessed intrahepatic fat state and changes: The DIRECT PLUS clinical trial
D Goldberg, Anat Yaskolka Meir, Gal Tsaban, et al.
Hepatology (2024)
Open Access | Times Cited: 3
Curcumin protects against high-fat diet-induced nonalcoholic simple fatty liver by inhibiting intestinal and hepatic NPC1L1 expression via down-regulation of SREBP-2/HNF1α pathway in hamsters
Jie Yang, Jun Zou, Haiyan Mai, et al.
The Journal of Nutritional Biochemistry (2023) Vol. 119, pp. 109403-109403
Closed Access | Times Cited: 9
MicroRNAs as Biomarkers and Therapeutic Targets for Nonalcoholic Fatty Liver Disease: A Narrative Review
Yu Sun, Yongming Shen, Xiurui Liang, et al.
Clinical Therapeutics (2023) Vol. 45, Iss. 3, pp. 234-247
Closed Access | Times Cited: 7
The NRF-2/HO-1 Signaling Pathway: A Promising Therapeutic Target for Metabolic Dysfunction-Associated Steatotic Liver Disease
Na Li, Liyuan Hao, Shenghao Li, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 8061-8083
Open Access | Times Cited: 2
Helminth infection and helminth-derived products: A novel therapeutic option for non-alcoholic fatty liver disease
Xi Liu, Yuyun Jiang, Jixian Ye, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 11
Exploring the Regulatory Role of ncRNA in NAFLD: A Particular Focus on PPARs
Anirban Goutam Mukherjee, Uddesh Ramesh Wanjari, Abilash Valsala Gopalakrishnan, et al.
Cells (2022) Vol. 11, Iss. 24, pp. 3959-3959
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top